Perspectives: Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
Study Details
Study Description
Brief Summary
This study will investigate and contrast the effects of two psychological treatments for adults with autism spectrum disorder. Cognitive Enhancement Therapy (CET) is a cognitive remediation intervention that aims to help adults with problems in thinking, planning, and socialization. Enriched Supportive Therapy (EST) is an individual supportive therapy that aims to help adults learn about their condition, manage their emotions and stress, improve their social skills, and cope with everyday problems.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Autism spectrum disorder (ASD) is characterized by marked impairments in social and non-social cognitive ability that persist well into adulthood and contribute to significant functional disability. The treatment of ASD has focused almost exclusively on children, and few empirically supported interventions are available to address the core cognitive and functional challenges individuals with ASD face as they transition to adulthood. This study will investigate and contrast the effects of two psychological treatments for adults with autism spectrum disorder. Cognitive Enhancement Therapy (CET) is a cognitive remediation intervention that aims to help adults with problems in thinking, planning, and socialization. Enriched Supportive Therapy (EST) is an individual supportive therapy that aims to help adults learn about their condition, manage their emotions and stress, improve their social skills, and cope with everyday problems.
Participation in this study will last 30 months. Potential participants must be able to attend weekly treatment sessions in Pittsburgh, PA.
The study design is a 30-month (2.5 years) randomized-controlled trial, where eligible participants will be randomized to the CET or EST study treatments. Participants will be treated with the study interventions for 18 months, and then followed for 12 additional months to assess the lasting impact of the study interventions. All participants will complete cognitive, clinical, and neuroimaging (magnetic resonance imaging) assessments prior to starting the study treatments and then at specified intervals thereafter to evaluate the impact of the study treatments on cognition, adaptive function, and the brain.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Cognitive Enhancement Therapy This research treatment aims to help with problems in thinking, planning, and socialization. Participants begin with cognitive training using computer software programs. They also participate in a small social-cognitive group to learn about their condition and how to act wisely in social situations by developing the abilities needed to understand another person's perspective, evaluate social contexts, and be foresightful. Time commitment: about 3½ hours per week; Location: Pittsburgh, PA only |
Behavioral: Cognitive Enhancement Therapy
An 18-month comprehensive, small group approach for the remediation of cognitive deficits in neurodevelopmental disorders consisting of individual sessions and 45 group training sessions in social cognition that are integrated with approximately 60 hours of computer assisted training in attention, memory, and problem solving skills.
|
Active Comparator: Enriched Supportive Therapy This research treatment uses individual supportive therapy to help adults learn about autism spectrum disorder, manage their emotions and stress, improve their social skills, and cope with everyday problems. Participants will learn about the impact of stress on their lives, and how to identify their own early cues of distress and apply effective coping strategies. Time commitment: about 1 hour per week; Location: Pittsburgh, PA only |
Behavioral: Enriched Supportive Therapy
An 18-month intervention that uses individual supportive therapy to help adults learn about autism spectrum disorder, manage their emotions and stress, improve their social skills, and cope with everyday problems. Participants will learn about the impact of stress on their lives, and how to identify their own early cues of distress and apply effective coping strategies.
|
Outcome Measures
Primary Outcome Measures
- Neurocognition [Pre-treatment, 9, 18, and 30 months]
Composite measure of neuropsychological tests designed to assess neurocognitive function
- Social cognition [Pre-treatment, 9, 18, and 30 months]
Composite measure of performance-based and interview tests designed to assess social-cognitive function
Secondary Outcome Measures
- Functional outcome [Pre-treatment, 9, 18, and 30 months]
Functional Assessment Battery (Social, Role, Vocational)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 16-45 years
-
Diagnosis of autism, Asperger's syndrome, or pervasive developmental disorder not otherwise specified (NOS) verified by the autism diagnostic observation schedule (ADOS) or autism diagnostic interview-revised (ADI-R)
-
Presence of significant social and cognitive disability, based on the Cognitive Style and Social Cognition Eligibility Interview (Hogarty et al., 2004)
-
Intelligence quotient (IQ) greater than 80
-
Ability to read and speak fluent English
-
Availability of a family member or close friend allowed to provide information on the participant
-
Ability to attend weekly treatment sessions in Pittsburgh, PA
Exclusion Criteria:
-
Organic brain syndrome
-
IQ < 80
-
English language skills below a sixth grade level
-
Persistent suicidal or homicidal behavior
-
History of substance abuse or dependence within the past 3 months
-
Comorbid attention deficit hyperactivity disorder (ADHD)
-
Comorbid personality disorder
-
History of disruptive or violent behavior
-
Any magnetic resonance imaging contraindications
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Pittsburgh | Pittsburgh | Pennsylvania | United States | 15213 |
Sponsors and Collaborators
- University of Pittsburgh
- National Institute of Mental Health (NIMH)
- Autism Speaks
- United States Department of Defense
- Pennsylvania Department of Health
Investigators
- Principal Investigator: Shaun M. Eack, PhD, University of Pittsburgh
- Principal Investigator: Nancy J. Minshew, MD, University of Pittsburgh
Study Documents (Full-Text)
None provided.More Information
Publications
- Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS. Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophr Res. 2007 Jan;89(1-3):308-11. Epub 2006 Oct 19.
- Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry. 2004 Sep;61(9):866-76.
- Hogarty GE, Greenwald DP, Eack SM. Durability and mechanism of effects of cognitive enhancement therapy. Psychiatr Serv. 2006 Dec;57(12):1751-7.
- MH085851
- R33MH085851
- R21MH085851
- AR100344
- 05381
- 2008NF-Autism
- ARI2014